Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Karolinska Development in connection with establishment of investment fund
Mandate

Vinge advises Karolinska Development in connection with establishment of investment fund

November 24, 2009

Vinge has advised Karolinska Development AB (publ) in connection with the establishment of an investment fund together with the European Investment Fund. The fund, which has a guaranteed capital of approximately EUR 30 million, will jointly invest together with Karolinska Development in Karolinska Development’s portfolio companies.

The Vinge team included partner Pontus Enquist and associates Maria Schultzberg and Joacim Rydergård.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026